Gainesville, FLNCT05811364Now EnrollingIRB Ready

Aortoiliac Occlusive Disease Clinical Trial in Gainesville, FL

Access cutting-edge aortoiliac occlusive disease treatment through this clinical trial at a research site in Gainesville. Study-provided care at no cost to qualified participants.

Sponsored by W.L.Gore & Associates

Quick Self-Assessment

See if you qualify for this Gainesville location

Preparing your pre-screening questions…

Expert Care in Gainesville

Access aortoiliac occlusive disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related aortoiliac occlusive disease treatment provided free

Apply for This Gainesville Location

Check if you qualify for this aortoiliac occlusive disease clinical trial in Gainesville, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Gainesville

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Gainesville site if eligible
  4. 4Begin participation

About This Aortoiliac Occlusive Disease Study in Gainesville

The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.

Sponsor: W.L.Gore & Associates

Who Can Participate

Inclusion Criteria

Age ≥ 18 years at time of informed consent signature
Informed Consent Form (ICF) is signed by the subject
Subject can comply with protocol requirements, including follow-up
Patient has symptomatic claudication, rest pain, or minor tissue loss (Rutherford Category 2-5)
Patient has de novo or restenotic lesion(s) found in the common and/or external iliac artery(ies)
Patient has: Unilateral or bilateral single or multiple lesions (\>50% stenosis or chronic total occlusion) each between 4 and 11 cm in length
Patient has a target vessel diameter visually estimated to be approximately between 5 mm and 13 mm
Patient has a sufficient (\<50% stenotic) common femoral artery and at least one sufficient (\<50% stenotic) femoral artery (deep or superficial).
Patient has at least one sufficient (\<50% stenotic) infrapopliteal run-off vessel.

Exclusion Criteria

Life expectancy \<1 year
Patient is pregnant at time of informed consent.
Patient has a known allergy to stent or stent graft components (including nitinol, stainless steel, or heparin).
Patient has severe chronic renal insufficiency (serum creatinine level \> 2.5mg/dL) and not undergoing hemodialysis.
Patient has evidence of a systemic infection.
Patient has a known intolerance to antithrombotic medications that prevent compliance with study or control device Instructions for Use.
Patient has had vascular catheterization of the lower extremities within 30 days of randomization (excluding diagnostic angiograms for the study procedure).
Patient has previous stenting in the iliac arteries.
Patient has previous surgical bypass in the target limb.
Patient is currently participating in another investigative clinical study unless received written approval by the sponsor.
Patient has a lesion requiring drug-coated balloon angioplasty, atherectomy, lithotripsy, or any ablative device to facilitate stent delivery.
Patient has an abdominal aortic artery lesion or aneurysm.
Patient has a lesion that requires stent placement within 2 cm of the inguinal ligament.
Patient has isolated common iliac artery stenosis that can be treated with a single device (i.e., common iliac artery stenosis that does not require kissing stents or extend into the external iliac artery).
Patient has outflow disease that requires concomitant interventions (i.e. common femoral endarterectomy or femoral / tibial revascularization).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Gainesville?

Yes, this clinical trial (NCT05811364) has an active research site in Gainesville, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Aortoiliac Occlusive Disease Treatment Options in Gainesville, FL

If you're searching for aortoiliac occlusive disease treatment options in Gainesville, FL, this clinical trial (NCT05811364) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Gainesville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced aortoiliac occlusive disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all aortoiliac occlusive disease clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Gainesville, FL

See all ankylosing spondylitis clinical trials recruiting in Gainesville — not just this study.

Browse Ankylosing Spondylitis Trials in Gainesville →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Gainesville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Gainesville, FL